Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 9.01%243.9M | 4.86%983.9M | 7.32%727.11M | 9.30%478.84M | 10.97%223.75M | 7.03%938.34M | 1.73%677.53M | 0.15%438.11M | 2.23%201.63M | 10.04%876.73M |
Operating revenue | 9.01%243.9M | 4.86%983.9M | 7.32%727.11M | 9.30%478.84M | 10.97%223.75M | 7.03%938.34M | 1.73%677.53M | 0.15%438.11M | 2.23%201.63M | 10.04%876.73M |
Other operating revenue | ---- | -12.46%41.63M | ---- | -10.07%18.78M | ---- | 10.05%47.56M | ---- | -25.87%20.89M | ---- | 10.83%43.22M |
Total operating cost | 6.92%184.98M | 5.60%758.45M | 6.10%550.96M | 7.21%363.22M | 8.15%173.01M | 3.66%718.26M | 5.68%519.3M | 4.39%338.8M | 9.38%159.97M | 12.20%692.91M |
Operating cost | 6.13%132.44M | 9.94%560.46M | 7.16%395.55M | 10.64%263.69M | 24.47%124.79M | 4.73%509.8M | 5.82%369.12M | 3.47%238.33M | 0.19%100.26M | 17.60%486.76M |
Operating tax surcharges | 1.78%3.48M | -1.85%14.52M | -0.89%10.9M | -0.28%7.03M | -7.78%3.42M | 2.30%14.79M | 1.35%11M | -0.64%7.05M | 11.57%3.71M | -1.01%14.46M |
Administration expense | 4.11%39.03M | -3.40%146.06M | 2.30%117.37M | -3.24%74.86M | -21.91%37.49M | 2.75%151.2M | 9.75%114.73M | 10.80%77.37M | 41.31%48M | -2.36%147.15M |
Financial expense | 36.15%4.68M | -0.45%22.47M | 33.04%13.91M | 28.92%8.88M | 0.76%3.44M | -22.05%22.57M | -37.07%10.45M | -41.16%6.89M | -45.07%3.41M | -6.45%28.95M |
-Interest expense (Financial expense) | -10.06%6.76M | ---- | 1.75%22.9M | 4.08%15.62M | 0.38%7.52M | ---- | -24.59%22.5M | -27.61%15.01M | -18.17%7.49M | -22.71%31.23M |
-Interest Income (Financial expense) | 48.64%-2.11M | ---- | 25.12%-9.07M | 16.64%-6.8M | 0.02%-4.1M | ---- | 9.75%-12.11M | 10.09%-8.16M | 9.71%-4.1M | 75.59%-2.36M |
Research and development | 38.25%5.35M | -24.87%14.95M | -5.41%13.24M | -4.43%8.75M | -15.56%3.87M | 27.63%19.89M | 32.49%13.99M | 64.11%9.16M | 71.71%4.58M | 110.24%15.58M |
Credit Impairment Loss | --3.83M | 43.50%-250.05K | -34.08%-364.84K | -34.08%-364.84K | ---- | -3.94%-442.54K | 6.32%-272.09K | 6.32%-272.09K | ---- | -1,346.34%-425.78K |
Other net revenue | 39.66%8.77M | -36.19%29.07M | -4.67%26.11M | -4.44%17.01M | -35.89%6.28M | 1.34%45.56M | 13.73%27.39M | 17.39%17.8M | 41.26%9.8M | -1.31%44.96M |
Fair value change income | ---- | 889.45%579.24K | ---- | ---- | ---- | -94.48%58.54K | ---- | ---- | ---- | --1.06M |
Invest income | -26.95%3.48M | -51.17%15.66M | -19.09%16.26M | -18.16%10.9M | -27.62%4.76M | -5.78%32.07M | 19.44%20.1M | 35.85%13.32M | 73.11%6.58M | 2.12%34.04M |
-Including: Investment income associates | ---- | ---- | ---- | -18.98%9.18M | ---- | ---- | ---- | 36.63%11.33M | ---- | -24.25%24.01M |
Asset deal income | ---- | -65.14%11.01K | -102.00%-633.25 | -102.00%-633.25 | ---- | -95.72%31.6K | --31.6K | --31.6K | --31.6K | -78.98%738.9K |
Other revenue | -3.77%1.46M | -5.54%13.07M | 35.63%10.21M | 37.14%6.47M | -52.36%1.52M | 45.02%13.84M | -0.22%7.53M | -16.44%4.72M | 1.59%3.18M | 9.30%9.54M |
Operating profit | 18.72%67.7M | -4.19%254.52M | 8.96%202.26M | 13.26%132.63M | 10.80%57.02M | 16.11%265.64M | -6.57%185.62M | -8.57%117.1M | -11.17%51.46M | 1.81%228.78M |
Add:Non operating Income | -14.60%105.09K | 71.38%2.41M | 245.67%2.25M | 424.00%2.22M | -51.64%123.06K | 97.00%1.4M | 46.86%649.88K | 187.11%424.15K | 581.76%254.44K | -9.69%712.34K |
Less:Non operating expense | 9,940.29%446.7K | 11.79%762.06K | -41.77%396.92K | -96.91%6.36K | -94.61%4.45K | -81.48%681.69K | 179.41%681.69K | 487.48%206.11K | 135.16%82.5K | 1,910.02%3.68M |
Total profit | 17.88%67.36M | -3.83%256.16M | 9.98%204.11M | 14.93%134.84M | 10.67%57.14M | 17.96%266.36M | -6.68%185.59M | -8.48%117.32M | -10.87%51.63M | 0.22%225.81M |
Less:Income tax cost | 21.99%16.35M | 0.63%63.95M | 10.81%47.22M | 15.90%30.56M | 10.11%13.4M | 13.45%63.55M | -2.98%42.61M | -11.53%26.37M | -8.84%12.17M | 10.76%56.02M |
Net profit | 16.62%51.01M | -5.23%192.2M | 9.73%156.89M | 14.66%104.28M | 10.84%43.74M | 19.45%202.81M | -7.72%142.98M | -7.56%90.95M | -11.48%39.46M | -2.83%169.79M |
Net profit from continuing operation | 16.62%51.01M | -5.23%192.2M | 9.73%156.89M | 14.66%104.28M | 10.84%43.74M | 19.45%202.81M | -7.72%142.98M | -7.56%90.95M | -11.48%39.46M | -2.83%169.79M |
Less:Minority Profit | 3.91%10.9M | 7.81%39.15M | 17.28%32.62M | 37.15%22.26M | 45.32%10.49M | 25.10%36.32M | 5.13%27.82M | -5.38%16.23M | -6.23%7.22M | 0.64%29.03M |
Net profit of parent company owners | 20.63%40.11M | -8.07%153.05M | 7.91%124.27M | 9.77%82.02M | 3.12%33.25M | 18.28%166.49M | -10.37%115.16M | -8.02%74.72M | -12.58%32.24M | -3.51%140.76M |
Earning per share | ||||||||||
Basic earning per share | 20.09%0.0825 | -8.08%0.3162 | 9.51%0.2568 | 10.64%0.1695 | 3.15%0.0687 | 18.29%0.344 | -11.68%0.2345 | -8.70%0.1532 | -12.60%0.0666 | -3.52%0.2908 |
Diluted earning per share | 20.80%0.0819 | -8.35%0.3119 | 8.02%0.2533 | 9.07%0.1671 | 1.80%0.0678 | 17.02%0.3403 | -11.68%0.2345 | -8.70%0.1532 | -12.60%0.0666 | -3.52%0.2908 |
Other composite income | ||||||||||
Total composite income | 16.62%51.01M | -5.23%192.2M | 9.73%156.89M | 14.66%104.28M | 10.84%43.74M | 19.45%202.81M | -7.72%142.98M | -7.56%90.95M | -11.48%39.46M | -2.83%169.79M |
Total composite income of parent company owners | 20.63%40.11M | -8.07%153.05M | 7.91%124.27M | 9.77%82.02M | 3.12%33.25M | 18.28%166.49M | -10.37%115.16M | -8.02%74.72M | -12.58%32.24M | -3.51%140.76M |
Total composite income of minority owners | 3.91%10.9M | 7.81%39.15M | 17.28%32.62M | 37.15%22.26M | 45.32%10.49M | 25.10%36.32M | 5.13%27.82M | -5.38%16.23M | -6.23%7.22M | 0.64%29.03M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.